BR0109891A - Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph - Google Patents

Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph

Info

Publication number
BR0109891A
BR0109891A BR0109891-8A BR0109891A BR0109891A BR 0109891 A BR0109891 A BR 0109891A BR 0109891 A BR0109891 A BR 0109891A BR 0109891 A BR0109891 A BR 0109891A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
composition containing
camptothecin derivative
adjusting substance
containing camptothecin
Prior art date
Application number
BR0109891-8A
Other languages
English (en)
Inventor
Shuichi Ando
Suichi Sugie
Masami Morita
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of BR0109891A publication Critical patent/BR0109891A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA CONTENDO DERIVADO DE CAMPTOTECINA E SUBSTâNCIA DE AJUSTE DE PH". Trata-se de uma preparação farmacêutica que assegura estabilidade e solubilidade de um derivado camptotecina hexacíclico preparado pela adição de um anel tendo um grupo solúvel em água a camptotecina, onde uma substância de ajuste de pH e, como ocasião demanda, um açúcar ou um álcool de açúcar são adicionados ao derivado de camptotecina hexacíclico.
BR0109891-8A 2000-04-07 2001-04-06 Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph BR0109891A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000111919 2000-04-07
JP2000169082 2000-06-01
PCT/JP2001/002982 WO2001076603A1 (en) 2000-04-07 2001-04-06 Medicinal compositions containing camptothecin derivative and ph regulating agent

Publications (1)

Publication Number Publication Date
BR0109891A true BR0109891A (pt) 2002-12-31

Family

ID=26590030

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109891-8A BR0109891A (pt) 2000-04-07 2001-04-06 Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph

Country Status (12)

Country Link
US (1) US20030109460A1 (pt)
EP (1) EP1310254A4 (pt)
KR (1) KR20030009426A (pt)
CN (1) CN1433310A (pt)
AR (1) AR030207A1 (pt)
AU (1) AU4874301A (pt)
BR (1) BR0109891A (pt)
CA (1) CA2405453A1 (pt)
MX (1) MXPA02009901A (pt)
NO (1) NO20024823L (pt)
RU (1) RU2002126558A (pt)
WO (1) WO2001076603A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
TW200727900A (en) * 2005-07-27 2007-08-01 Yakult Honsha Kk Aqueous solution preparation containing camptothecins
CN104524588A (zh) * 2014-12-05 2015-04-22 天津键凯科技有限公司 一种聚乙二醇修饰的喜树碱类衍生物的药物组合物及其制备方法
HUE060364T2 (hu) 2019-03-29 2023-02-28 Medimmune Ltd Vegyületek és konjugátumaik
US11806405B1 (en) 2021-07-19 2023-11-07 Zeno Management, Inc. Immunoconjugates and methods
TW202320858A (zh) 2021-07-19 2023-06-01 美商薩諾管理公司 免疫接合物及方法
CN118496288B (zh) * 2023-02-06 2025-01-10 中国科学院微生物研究所 一种糖基化喜树碱类化合物Gly-CPTR及其制药用途、药物或前药及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693760A (en) * 1988-04-14 1997-12-02 Incyte Pharmaceuticals, Inc. Method of causing selective immunosuppression using HL-60 related lectins
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
JPH0770195A (ja) * 1993-08-23 1995-03-14 Yutaka Mizushima 糖修飾インターフェロン
US6504029B1 (en) * 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
JP2000044567A (ja) * 1998-07-29 2000-02-15 Dai Ichi Seiyaku Co Ltd 六環性化合物

Also Published As

Publication number Publication date
NO20024823D0 (no) 2002-10-04
AU4874301A (en) 2001-10-23
WO2001076603A1 (en) 2001-10-18
EP1310254A4 (en) 2006-05-10
KR20030009426A (ko) 2003-01-29
EP1310254A1 (en) 2003-05-14
CN1433310A (zh) 2003-07-30
CA2405453A1 (en) 2002-10-03
NO20024823L (no) 2002-12-06
AR030207A1 (es) 2003-08-13
MXPA02009901A (es) 2003-05-27
US20030109460A1 (en) 2003-06-12
RU2002126558A (ru) 2004-03-20

Similar Documents

Publication Publication Date Title
BR0112417A (pt) Composições farmacêuticas contendo composto dds
TR200101335T2 (tr) İktidarsızlık tedavisi için pirazolopirimidinon türevleri
WO2002012242A3 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
NO961136L (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
DK0503548T3 (da) Cykliske ureaderivater, lægemidler indeholdende disse, og fremgangsmåde til deres fremstilling.
EA200300354A1 (ru) Хинолиноновые производные в качестве ингибиторов тирозинкиназы
NO20020925L (no) N-heterosykliske derivater av NOS-inhibitorer
WO2001087882A3 (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
EA200301047A1 (ru) Противоопухолевые составы, содержащие производные таксанов
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
WO2001089571A3 (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
DK0525307T3 (da) Stabile præparater til parenteral indgivelse og deres anvendelse
DK0982990T3 (da) Stabile flydende sammensætninger indeholdende calciumascorbat, fremgangsmåde til deres fremstilling og anvendelse heraf
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
BR0109891A (pt) Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph
FI944823A0 (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
EP1305322A4 (en) DERIVATIVES OF CHAIN-DERIVED LIPOPHILES MOLECULES AND THEIR USE
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
WO2003053337A3 (en) Therapeutic compositions
WO2005041876A3 (en) Spill resistant formulations containing clays
DE69030052D1 (de) Lösliche, nichttoxische Derivate von basischen Polyenmakroliden, ihre Herstellung und Verwendung
WO2004056832A3 (en) Epothilone derivatives
EE05319B1 (et) Akrloldistamtsiini derivaati sisaldav farmatseutiline kompositsioon, derivaadi kasutamine tuumorivastase ravimi valmistamiseks ning kombineeritud ravimpreparaat
HRP20050787A2 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.